Publications
Jump to: 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2000-2002
2009
Chapin E, Zhan M, Hsu VD, Seliger SL, Walker LD, Fink JC. Adverse safety events in chronic kidney disease: the frequency of "multiple hits." Clin J Am Soc Nephrol. In press.
Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 2009; 169 (12):1156-1162.
Fink JC, Brown J, Hsu VD, Seliger SL, Walker L, Zhan M. Chronic kidney disease as an under-recognized threat to patient safety. Am J Kidney Dis 2009; 53:681-688.
Gruber-Baldini A, Stuart BC, Zuckerman IH, Hsu VD, Boockvar KS, Zimmerman S, Kittner SJ, Quinn CC, Hebel R, May C, Magaziner JS. Sensitivity of nursing home cost comparisons to method of dementia diagnosis ascertainment. Int J Alzheimers Dis 2009, Volume 2009; Article ID 780720, 10 pages. doi:10.4061/2009/780720.
Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, Fink JC. The frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009; doi:10.2215/CJN.00800209.
Onukwugha E, Zuckerman, IH, McNally, D, Coyne, KS, Vats, V, Mullins, CD. The total economic burden of overactive bladder in the United States: a disease-specific approach. Am J Manag Care 2009;15:S90-S97.
Otsuki M, Eakin MN, Rand CS, Butz AM, Hsu VD, Zuckerman, IH, Ogborn J, Bilderback A, Riekert KA. Medication adherence feedback to improve asthma outcomes among inner-city children: a randomized controlled trial. Pediatrics. In press.
Zuckerman, IH, Rapp, T, Onukwugha E, Davidoff, A, Choti, MA, Gardner, J, Seal, B, Mullins, CD. Effect of age on survival benefit of adjuvant chemotherapy in elderly stage III colon cancer patients. J Am Geriatr Soc 2009 Jun 25 [Epub ahead of print].
2008
Butz AM, Thompson RE, Tsoukleris MG, Donithan M, Hsu VD, Mudd K, Zuckerman IH, Bollinger ME. Seasonal patterns of controller and rescue medication dispensed in underserved children with asthma. J Asthma 2008; 45:9, 800-806.
Korelitz JJ, Zito JM, Gavin NI, Masters MN, McNally D, Irwin DE, Kelleher K, Bethel J, Xu Y, Rubin J, Mattison DR. Asthma-related medication use among children in the United States. Ann Allergy Asthma Immunol 2008; 100: 222-229.
Seliger SL, Zhan M, Hsu VD, Walker LD, Fink JC. Chronic kidney disease adversely influences patient safety. J Am Soc Nephrol 2008; 19:2414-2419.
Zito JM, Safer DJ, Sai D, Gardner JF, Thomas D, Coombes P, Dubowski M, Mendez-Lewis M. Psychotropic medication patterns among youth in foster care. Pediatrics 2008; 121: e157-e163.
Zito JM, Safer DJ, de Jong-van den Berg LTW, Janhsen K, Fegert JM, Gardner JF, Glaeski G, Valluri SC. A three-country comparison of psychotropic mediation prevalence in youth. Child Adolesc Psychiatr Mental Health 2008; 2:26.
Zito JM, Valluri SC, Ballard E, Safer DJ, Korelitz JJ, Magder L, Pao M. Pediatric cancer and antidepressant use (abstract). Published in the Abstracts of 2008 Annual Meeting of American Psychiatric Association, Washington, D.C. May 3-8, 2008.
2007
Fink JC, Hsu VD, Zhan M, Walker LD, Mullins CD, Jones-Burton C, Langenberg P, Seliger SL. Center effects in anemia management of dialysis patients. Journal of the American Society of Nephrology. 2007;18:646-653.
Spolter YS, Seliger SL, Zhan M, Hsu VD, Walker LD, Fink JC. The relationship between dialysis performance measures: adequacy and anemia management. American Journal of Kidney Disease. 2007; 50:774-781.
Zito JM, Safer DJ, Valluri S, Gardner JF, Korelitz JJ, Mattison DR: Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. J Child Adolesc Psychopharmacol 2007, 17: 195-203.
Zuckerman IH, Sato M, Hsu VD, Hernandez JJ. Validation of a method for identifying nursing home admissions using administrative claims. BMC Health Services Research. 2007:7:202.
2006
Butz AM, Tsoukleris M, Donithan M, Hsu VD, Mudd K, Zuckerman IH, Bollinger ME. Patterns of inhaled anti-inflammatory medication use in young underserved children with asthma. Pediatrics 2006;118;2504-2513.
Butz AM, Tsouklesis M, Donithan M, Hsu VD, Zuckerman I, Mudd K, Thompson RE, Rand C, Bollinger MB. Effectiveness of nebulizer use targeted asthma education on underserved children with asthma. Archives of Pediatrics and Adolescent Medicine. 2006;160:622-628.
Chauncey DM, Mullins CD, Tran BV, McNally D, McEwan RN. Medication access through patient assistance programs. American Journal of Health-System Pharmacy. 2006;63(13):1254-1259.
Mudd K, Bollinger ME, Hsu VD, Donithan M, Butz A. Pharmacy fill patterns in young, urban children with persistent asthma. Journal of Asthma. 2006;43:597-600.
Simoni-Wastila L, Singhal PK, Briesacher B, Zuckerman IH, Hsu VD. National estimates of exposure to prescription drugs with addiction potential in community-dwelling elders. Substance Abuse. 2006;26(1):35-44.
Zito JM., Safer DJ, Gardner JF, Soeken K, Ryu J. Anticonvulsant Treatment for Psychiatric and Seizure Indications Among Youths. Psychiatric Services. 2006;57(5):681-685.
Zito JM, Tobi H, de Jong-van den Berg LTW, Fegert JM, Safer DJ, Janhsen K, Hansen DG, Gardner JF, Glaeske G. Antidepressant prevalence for youths: a multi-national comparison. Pharmacoepidemiology and Drug Safety 2006; 15(11): 793-798.
2005
Cluxton RJ, Li Z, Heaton PC, Weiss SR, Zuckerman IH, Moomaw CJ, Hsu VD, Rodriguez EM. Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance findings from the state of Ohio Medicaid program. Pharmacoepidemiology and Drug Safety 2005;14:1-9.
dosReis S, Zito JM, Safer DJ, Gardner JF, Puccia KB, Owens PL. Multiple psychotropic medication use for youth: A two state comparison. Journal of Child & Adolescent Psychopharmacology 2005;15(2):68-77.
Jones-Burton C, Seliger SL, Brown J, Stackiewicz L, Hsu VD, Fink JC. Racial variations in erythropoietic response to epoetin alfa in chronic kidney disease and the impact of smoking. Nephrology Dialysis Transplantation 2005;20:2739-2745.
Mullins CD, DeVries AR, Hsu VD, Meng FL, Palumbo FB. Variability and growth in specialty pharmaceuticals expenditures. Health Affairs. Health Affairs 2005;24:1117-1127.
Stuart BS, Gruber-Baldini AL, Fahlman C, Quinn CC, Burton LB, Zuckerman IH, Hebel JR, Zimmerman S, Singhal PK, Magaziner J. Medicare cost differences between nursing home patients admitted with and without dementia. The Gerontologist 2005;45(4):505-515.
Zito JM, Safer DJ, Zuckerman IH, Gardner JF, Soeken K. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services 2005;56(2):157-163.
2004
Hillman JJ, Zuckerman IH, Lee E. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program. Journal of Women's Health 2004;13(9):986-992.
Lee E, McNally DL, Zuckerman IH. Evaluation of a physician-focused educational intervention on Medicaid children with asthma. Annals of Pharmacotherapy 2004;38:961-966.
Mullins CD, Cooke JL, Wang J, Shaya FT, Hsu VD, Brooks S. Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in Medicaid. Journal of the National Medical Association 2004;96(6):809-816.
Mullins CD, Shaya FT, Flowers LR, Saunders E, Johnson W, Wong W. Health care cost of analgesic use in hypertensive patients. Clinical Therapeutics 2004;26(2):285-293.
Mullins CD, Snyder SE, Wang J, Cooke JL, Baquet C. Economic Disparities in Treatment Costs among Ambulatory Medicaid Cancer Patients. Journal of the National Medical Association 2004;96(12):1565-1574.
Mullins CD, Wang J, Cooke JL, Blatt L, Baquet CR. Longitudinal versus cross-sectional methodology for estimating the economic burden of breast cancer. A pilot study. Pharmacoeconomics 2004;22(5):285-291.
Safer DJ, Zito JM, Gardner JF. Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths. Psychiatric Services 2004;55(9):1049-1051.
Zuckerman IH, Menis M, McNally DL, Layne BA, Mullins CD. Intervention for decreasing excessive acetaminophen use in Pennsylvania Medicaid recipients. American Journal of Health-System Pharmacy 2004;61(22):2410-2414.
Zuckerman IH, Weiss SR, McNally DL, Layne B, Mullins CD, Wang J. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost. American Journal of Managed Care 2004;10:493-500.
2003
Cohen LA, Magder LS, Manski RJ, Mullins CD. Hospital admissions associated with nontraumatic dental emergencies in a Medicaid population. American Journal of Emergency Medicine 2003;21:540-544.
Cohen LA, Manski RJ, Magder LS, Mullins CD. A Medicaid population's use of physicians' offices for dental problems. American Journal of Public Health 2003;93:1297-1301.
Doshi JA, Zuckerman IH, Picot SJ, Wright JT, Hill-Westmoreland EE. Antihypertensive use and adherence and blood pressure stress response among black caregivers and non-caregivers. Applied Nursing Research 2003;16(4):266-277.
Shaya FT, Blume S, Mullins CD. Increases in patient co-pays outpaced overall drug spending in 2001. Spotlight in Maryland - Issue Brief - Maryland Health Care Commission. September 2003.
Shaya FT, Blume S, Mullins CD. Patient liability for prescriptions: trends in Maryland, methodology and results. Report to the Maryland Health Care Commission. October 2003.
Simoni-Wastila L, Singhal PK, Hsu VD, Gardner J, Briesacher B, Zuckerman IH. Potentially problematic drug use in community-dwelling elders: Report to Johnson, Bassin and Shaw, Inc. 2003.
Stuart B, Kamal-Bahl S, Briesacher B, Lee E, Doshi J, Zuckerman IH, Verovsky I, Beers MH, Erwin G, Friedley N. Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. American Journal of Geriatric Pharmacotherapy 2003;1:61-74.
Stuart B, Singhal PK, Magder LS, Zuckerman IH. How robust are health plan quality indicators to data loss? A Monte Carlo simulation study of pediatric asthma treatment. Health Services Research 2003;38(6):1547-1561.
Zito JM, Safer DJ, dosReis S, Gardner JF, Madger L, Soeken K, Boles M, Lynch F, Riddle MA. Psychotropic practice patterns for youth. A 10-year perspective. Archives of Pediatrics & Adolescent Medicine 2003;157:17-25.
2000-2002
Ammerman DK, Zuckerman IH, Hsu VD. Drug interactions with erythromycin and clarithromycin among Maryland Medicaid long-term care facility residents. Consultant Pharmacist 2000;15:67-73.
Blaisdell CJ, Weiss SR, Kimes DS, Levie ER, Myers M, Timmins S, Bollinger ME. Using seasonal variations in asthma hospitalizations in children to predict Hospitalization frequency. Journal of Asthma 2002;39(7):567-575.
Cohen LA, Manski RJ, Magder LS, Mullins CD. Dental visits to hospital emergency departments by adult receiving Medicaid. Journal of the American Dental Association 2002;133:715-724.
Lee E, Zuckerman IH, Weiss SR. Patterns of pharmacotherapy and counseling for osteoporosis management in visits to US ambulatory care physicians by women. Archives of Internal Medicine 2002;162(20):2362-2366.
Maryland Asthma Control Program. Department of Health and Mental Hygiene Family Health Administration. Asthma in Maryland 2002.
Weiss SR, Zuckerman IH, Huang X, Hsu VD. Clinical correlates of estrogen replacement therapy use and duration of use among Medicaid recipients. Journal of Women's Health & Gender-Based Med 2001;10(8):811-819.
Zuckerman IH, Stuart B, Magder LS, Bollinger ME, Weiss SR. Adherence to asthma treatment guidelines among children in the Maryland Medicaid program. Current Therapeutic Research 2000;61:912-924.
Presentations
Jump to: 2009, 2008, 2007, 2006, 2005, 2004
2009
Adams JL, Fink JC, Seliger SL, Walker L, Hsu VD, Fox KM, Bradbury BD, Gandra SR. Modeling of the decision to treat anemic chronic kidney disease (CKD) patients with transfusion of ESAs. Presented at the 31st Annual Meeting of the Society for Medical Decision Making, Hollywood, CA. October 18-21, 2009.
Fink JC, Seliger SL, Fox K, Gandra SR, Walker L, Hsu VD, Bradbury B, Adams JL. Center effects on anemia management of patients with CKD-related anemia. Presented at the American Society of Nephrology Meeting, San Diego, CA. October 27-November 1, 2009.
Mullins CD, Hsu VD, Cooke, C, Shelbaya A, Wallace A, Perencevich E. Linezolid vs. vancomycin: re-hospitalization rates among patients with pneumonia, staphylococcal infection, and skin and soft tissue infection. Presented at the 47th Annual Meeting of the Infectious Diseases Society of American, Phailadelphia, PA. October 29-November 1, 2009.
Mullins CD, Hsu VD, Shorr A, Cooke C, Shelbaya A, Perencevich E. Linezolid versus vancomycin health and economic outcomes: a retrospective database study of 11,018 infection-related hospitalization treatment episodes. Presented at the 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland. May 16-19, 2009.
Seliger SL, Fox K, Gandra SR, Bradbury B, Hsu VD, Walker L, Chiou CF, Fink JC. Propensity-matched analysis of early versus delayed initiation of ESAs in stage 3-4 chronic kidney disease (CKD). Presented at the American Society of Nephrology Meeting, San Diego, CA. October 27-November 1, 2009.
Seliger SL, Fox KM, Gandra SR, Hsu VD, Fink JC. Differences in hospitalization between early versus delayed initiation of ESAs in chronic kidney disease patients not on dialysis. To be presented at the ASHP 2009 Midyear Clinical Meeting, Las Vegas, NV. December 6-10, 2009.
Seliger SL, Walker L, Hsu VD, Fink JC. Trends in iodinated contrast and gadolinium-based contrast exposure in a national CKD cohort: 2002-2006. Presented at the American Society of Nephrology Meeting, San Diego, CA. October 27-November 1, 2009.
2008
Davidoff A, Choti MA, Zuckerman IH, Obeidat N, Onukwugha E, Sullivan P, Gardner J, Mullins CD, Hanna N. Is there evidence of diminishing disparities in use of adjuvant chemotherapy among elderly Stage III colon cancer patients? Presented at the 2008 Gastrointestinal Cancers Symposium, Orlando, FL. January 25-28, 2008.
Onukwugha E, Hanna N, Mullins CD, Sullivan P, Zuckerman IH, Hsu VD, Choti MA. The benefit of adjuvant chemotherapy in stage III colon cancer patients with multiple positive nodes: a population-based analysis. Presented at the 2008 Gastrointestinal Cancers Symposium, Orlando, FL. January 25-28, 2008.
Simoni-Wastila L, Shaffer T, Hsu VD, Mullins CD, Qian J, Yang HWK, Chen CC, Kim E, Whitehead R. Antipsychotic metabolic propensity and polytherapy: influence on hospitalization. Presented at the ISPOR 13th Annual International Meeting, Toronto, ON, Canada. May 3-7, 2008.
Tommasello AC, Dailey V, Wei YJ, Hsu VD, Treherne L, Flaim C. HAART prescribing is significantly associated with housing status. Presented at the National Housing and HIV/AIDS Research Summit III, Baltimore, MD. March 5-7, 2008.
Tsoukleris MG, Hsu, VD, Bollinger ME, Land CL, Walker J, Vibbert CL, Butz AM. One item screening to identify high risk children with asthma? Presented at the American Thoracic Society 2008 Meeting, Toronto International Conference, Toronto, ON, Canada. May 16-21, 2008.
Zito JM, Kouzis A, Gardner JF, Korelitz J, Mattison D. Sociodemographic determinants of psychotropic medication use in a Medicaid-insured youth population. Presented at AcademyHealth, Washington, DC, June 8-10, 2008.
Zito JM, Valluri S, Hundley SC, Safer DJ, Gardner JF, Maneval M, Korelitz JJ, McNally DL, Taylor-Zapata P, Mattison DR. Impact of comorbid disruptive disorders on pharmacotherapy for attention-deficit/hyperactivity disorder in publicly-insured US youth. Presented at the International Society of Pharmacoepidiemiology Society, Copenhagen, Denmark, August 17-20, 2008.
Zuckerman I, Mullins D, Seal B, Sullivan P, Rapp T, Davidoff A, Gardner J, Obeidat N, Pandya N, Choti M. Effect of age on survival benefit of adjuvant chemotherapy in elderly stage III colon cancer patients: a population-based analysis. Presented at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, IL. May 30-June 3, 2008.
2007
Frequency of medication usage in the pediatric population. National Institute of Health and Human Development, Bethesda, MD. Contract NO. GS-23F-8144H. Task Order No. HHSN275200403388C.6100 Executive Blvd. Bethesda, MD 20892-7510. September 2007.
Seliger SL, Hsu VD, Walker L, Fink JC. Factors associated with incident Eythropoiesis-Stimulating Agent (ESA) use in Chronic Kidney Disease (CKD). Poster presentation at the American Society of Nephrology Meeting, San Francisco, CA. October 31-November 5, 2007
Seliger SL, Hsu VD, Walker L, Fink JC. Frequency of higher hemoglobins (Hb) among veterans with Chronic Kidney Disease (CKD) treated with Erythropoiesis-Stimulating Agents (ESA): Findings from the National Veterans Health Administration (VHA) database. Poster presentation at the American Society of Nephrology Meeting, San Francisco, CA. October 31-November 5, 2007.
Seliger SL, Hsu VD, Walker L, Fink JC. Chronic Kidney Disease (CKD) and patient safety indicators. Podium presentation at the American Society of Nephrology meeting, San Francisco, CA. October 31-November 5, 2007
Seliger SL, Hsu VD, Walker L, Fink JC. Trends in prevalence and management of anemia in chronic kidney disease in the Veterans Health Administration. Poster presentation at the National Kidney Foundation 2007 Spring Clinical Meetings, Orlando, FL. April 13-17, 2007.
Tai K, Tsoukleris MG, Hsu VD, Zuckerman IH, Bollinger ME, Mudd K, Donithan M, Butz AM. Utilization of non-traditional and alternative therapies in inner city under-served children with asthma. Podium presentation at the 2007 American Academy of Allergy Asthma and Immunology Annual Meeting, San Diego, CA. February 23-27, 2007.
Tsoukleris MG, Hsu VD, Vibbert CL, Bollinger ME, Butz AM. Asthma controller awareness, knowledge, health beliefs and behaviors. Poster presentation at the 2007 American Academy of Allergy Asthma and Immunology Annual Meeting, San Diego, CA. February 23-27, 2007.
Vibbert CL, Butz AM, Tsoukleris MG, Hsu VD, Bollinger ME. Does use of asthma controllers really indicate asthma “control”? Podium presentation at the 2007 American Academy of Allergy Asthma and Immunology Annual Meeting, San Diego, CA. February 23-27, 2007.
Valluri SC, Zito JM, Safer, DJ, Gardner JF, McNally DL, Korelitz JJ, Mattison DR. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. Poster presentation at the 135th Annual Meeting of APHA, Washington, DC. November 3-7, 2007.
Zito JM, Safer DJ, Ferget JM, de Jon van den Berg LTW, Janhsen K, Gardner JF, Ryu J. A multinational comparison of psychotropic prevalence in youth. Poster presentation at the 54th Annual Meeting of American Academy of Child & Adolescent Psychiatry, Boston, MA. October 23-28, 2007.
Zito JM, Safer DJ, Sai D, Gardner JF, Valluri SC, Thomas D, Coomnes P, Dubowski M, Mendex-Lewis M. Psychotherapeutic medication patterns amongst foster care youths. Poster presentation at the 54th Annual Meeting of American Academy of Child & Adolescent Psychiatry, Boston, MA. October 23-28, 2007.
Zito JM, Safer DJ, Valluri SC, Gardner JF, Korelitz JJ, Mattison DR. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. Podium presentation at the 2007 Child Health Services Research Meeting, Orlando, FL. June 2, 2007.
Zito JM, Korelitz JJ, Valluri SC, Gardner JF, Bethel, J, Mattison, DR. Comparing medication use prevalence estimates from US claims data by two methods. Poster presentation at the 23rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Quebec City, Canada. August 19-22, 2007.
Zuckerman IH, Sato M, Hsu VD, Hernandez JJ. Validation of a method for identifying nursing home admissions using administrative claims. Poster presentation at The Gerontological Society of America 60th Annual Scientific Meeting, San Francisco, CA. November 16-20, 2007.
2006
Frequency of Medication Usage in the Pediatric Population. National Institute of Child Health and Human Development. Contract No. GS-23F-8144H. Task Order No. HHSN275200403388C. 6100 Executive Blvd. Bethesda, MD 20892-7510. October 31, 2006.
Bollinger MB, Boldt A, Mudd K, Manning A, Tsoukleris M, Hsu VD, Butz AM. Prescription fill patterns in underserved children with asthma. Podium presentation at the 2006 American Academy of Allergy Asthma and Immunology Annual Meeting, Miami Beach, FL. March 3-7, 2006.
Mudd K, Bollinger MB, Hsu VD, Butz AM. Asthma medication use in young inner-city asthmatic children. Podium presentation at the 2006 American Academy of Allergy Asthma and Immunology Annual Meeting, Miami Beach, FL. March 3-7, 2006.
Tai K, Tsoukleris MG, Zuckerman IH, Bollinger MB, Mudd K, Donithan M, Hsu VD, Butz AM. Utilization of non-traditional and alternative therapies in inner city under-served children with asthma. Poster presentation at the University of Maryland School of Pharmacy Graduate Student Research Day, Baltimore, MD. May 17, 2006.
2005
Frequency of Medication Usage in the Pediatric Population. National Institute of Child Health and Human Development. Contract No. GS-23F-8144H. Task Order No. HHSN275200403388C. 6100 Executive Blvd. Bethesda, MD 20892-7510. October 2005.
Hodgkin D, Thomas CP, Ritter G, Lee S, Leung L, Simoni-Wastila L, Hsu VD, Zhou Q, Epstein D. Impact of a three-tier formulary on utilization of antidepressant medications. Poster presentation at the Annual meeting of the International Health Economics Association, Barcelona, Spain. July 10, 2005.
Hodgkin D, Thomas CP, Simoni-Wastila L, Ritter GA, Lee S, Hsu VD. Impact of a three-tier formulary on utilization of antidepressant medications. Poster presentation at the American Public Health Association 133rd Annual Meeting, Philadelphia, PA. December 10-14, 2005.
Hsu VD. Operating a research center: The Pharmaceutical Research Computing experience. Podium presentation at the University of Tennessee College of Pharmacy, Memphis, TN. April 19, 2005.
Mudd K, Bollinger MB, Hsu VD, Donithan M, Butz AM. Asthma and pharmacy refill data in minority asthmatic children. Poster presentation at the American Academy of Allergy Asthma and Immunology 61st Annual Meeting, San Antonio, TX. March18-22, 2005.
Mullins CD, Shaya FT, Zito J, Gardner J, McNally D, Meng F, Harrison D. Starting dose and persistence for ziprasidone users in Medicaid. Poster presentation at the International Society for Pharmacoeconomics and Outcomes Research 10th Annual International Meeting Washington, DC. May 15-18, 2005.
Mullins CD, Shaya FT, Zito J, Gardner J, McNally D, Meng F, Harrison D. Starting dose and persistence for ziprasidone users in Medicaid. Poster presentation at the American Psychiatric Association Annual Meeting, Atlanta, GA. May 21-26, 2005.
Quinn C, Gruber-Baldini A, Buie VC, May C, Silva A, Burton L, Kittner S, Zuckerman IZ, Hsu VD, Zimmerman S. Diabetes quality of care among nursing home new admission cohort. Podium presentation at the Academy Health Annual Research Meeting 2005, Boston, MA. June 26-28, 2005.
Thomas CP, Hodgkin D, Ritter G, Lee S, Leung M, Simoni-Wastila L, Hsu VD, Epstein D, Zhou Q. Impact of a three-tier formulary on asthma treatment. Podium presentation at the Building Bridges Conference, American Association of Health Plans, Santa Fe, NM. April 7, 2005.
Tran BV, Mullins CD, Shaya FT, McNally D, McEwan RN. Medication needs of elderly individuals without prescription drug coverage. Poster presentation at the International Society for Pharmacoeconomics and Outcomes Research 10th Annual International Meeting Washington, DC. May 15-18, 2005.
Zito JM, Safer DL, Gardner JF, Tobi H, de Jong-van den Berg LTW, Fegert J, Glaeske G, Janhsen K, Ryu J. Antipsychotic medication utilization: A comparison of US, Dutch, and German youth. Poster presentation at the 45th Annual New Clinical Drug Evaluation Unit Meeting, Boca Raton, FL. June 6-9, 2005.
Zuckerman IH, Suh E, McNally D, Layne B, Weiss SR. Evaluation of an educational intervention to improve pharmacologic management of migraine. Poster presentation at the American Public Health 133rd Annual Meeting, Philadelphia, PA. December 10-14, 2005.
2004
Hernandez JJ, McNally D, Layne B, Simoni-Wastila L, Zuckerman IH. Evaluation of the Pennsylvania OxyContin® Intensified Intervention: Impact on drug and services utilization and expenditures. Poster presentation at the 132nd American Public Health Annual Meeting, Washington, DC. November 8, 2004.
Simoni-Wastila L, Singhal P, Hsu VD, Gardner J, Zuckerman IH, Briesacher B. Use of abusable prescription drugs by community-dwelling elders. Podium presentation at the 132nd Annual Meeting of American Public Health Association, Washington, DC. November 8, 2004.
Zuckerman IH, McNally DL, Weiss Smith S., Simoni-Wastila L. Evaluation of a Cox-2 inhibitor prior authorization program on utilization and expenditures. Podium presentation at the 20th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Bordeaux, France. August 22-25, 2004.
Zuckerman IH, Weiss SR, McNally D, Layne BL, Mullins CD, Wang J. Impact of an outpatient physician education program on beta-blocker usage for secondary prevention of myocardial infarction. Poster presentation at the 20th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Bordeaux, France. August 22-25, 2004.
Zuckerman IH, Weiss SR, McNally DL, Mullins CD, Layne B. An educational program to increase the use of beta-blockers following an acute myocardial infarction. Podium presentation at the American Drug Utilization Review Society Meeting, Clearwater, FL. February 20, 2004.